Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microvascular Resistance in Women With Chest Pain and No or Minimal Coronary Artery Disease
2011-002630-39Phase 4Completed
- Sponsor
- Oslo University Hospital
- Start
- May 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of ulinastatin in Ischemia with non-obstructed coronary arteries (INOCA) and Coronary Small Vessel Disease (CMD), sponsored by Oslo University Hospital. Primary endpoint: Change in index of microvascular resistance. Started May 2012; status: completed.
02
Drugs
ulinastatin
03
Conditions
Ischemia with non-obstructed coronary arteries (INOCA)Coronary Small Vessel Disease (CMD)
Beyond the preview
Go deeper on 2011-002630-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002630-39.